Bicara Therapeutics (BCAX) Common Equity (2023 - 2026)
Bicara Therapeutics (BCAX) recorded Common Equity of $468.77 million in Q2 2026, up 7.7% from $435.2 million a year earlier but down 8.8% from the prior quarter.
Powered by 
Analysis
Bicara Therapeutics (BCAX) Common Equity (2023 - 2026) Analysis & Trends
At the end of FY2025, Bicara Therapeutics reported Common Equity of $401.45 million, down 18.4% from FY2024.
- Across earlier years, Common Equity came in at $491.88 million in FY2024 and -$148.77 million in FY2023.
- Quarterly Common Equity has ranged from -$174.78 million in Q2 2024 to $513.96 million in Q1 2026 over the past five years.
- On a year-over-year basis, Common Equity rose in two of the last four quarters, with an average decline of 4.9%.
- Per Business Quant, the preceding three quarters came in at $513.96 million (Q1 2026), $401.45 million (Q4 2025) and $402.78 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Bicara Therapeutics | 1.24 Bn | 1.24 Bn | - | 468.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 468.77 Mn |
| Mar 31, 2026 | 513.96 Mn |
| Dec 31, 2025 | 401.45 Mn |
| Sep 30, 2025 | 402.78 Mn |
| Jun 30, 2025 | 435.20 Mn |
| Mar 31, 2025 | 458.96 Mn |
| Dec 31, 2024 | 491.88 Mn |
| Sep 30, 2024 | 509.56 Mn |
| Jun 30, 2024 | -174.78 Mn |
| Mar 31, 2024 | -160.08 Mn |
| Dec 31, 2023 | -148.77 Mn |
| Sep 30, 2023 | -137.11 Mn |
API Access
Bicara Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BCAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BCAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BCAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();